Person: Peter Hoskins

Sign in

Person: Peter Hoskins

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Cancer research firm under threat

CANCER drug research firm EiRx Therapeutics said it will cease trading next week unless it completes a fundraising.

Wed, 06 Feb, 2008